Did you know that CKD-aP, a relentless itch affecting up to 70% of dialysis patients, is often overlooked despite its profound impact on quality of life? At CSL Vifor, we’re driving awareness and championing patient-centered care for those affected by this condition. In a recent article for The Parliament Magazine, we highlighted the importance of understanding patient-reported outcomes to address CKD-aP's impact. Joining the conversation, Daniel Gallego, President of the European Kidney Patients’ Federation, shares six actionable recommendations to enhance care for CKD-aP across Europe. Let’s make CKD-aP a priority in kidney care—together, we can go #BeyondItching to improve patients’ lives. Read more https://bit.ly/3UWfIi7
What Is Iron Deficiency Day?
Since 2015, CSL Vifor has marked Iron Deficiency Day on 26 November to shine a light on a global health concern: iron deficiency and iron deficiency anemia (IDA).
We have released our 2024 Annual Report Click here to read the Annual Report → | We have announced our 2024 Full Year Financial Results for the period ending June 30th 2024. Click here to view Information and Webcast Recording →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia